Matteo Scita
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effective treatment with preventing skeletal-related event development in multiple myeloma patients.
Effective treatment with preventing skeletal-related event development in multiple myeloma patients.
Journal: Expert review of hematology
Published: July 22, 2026
Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.
Journal: Annals of hematology
Published: March 11, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.
Journal: Cancer gene therapy
Published: November 27, 2025
Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma.
Journal: Haematologica
Published: September 30, 2025
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease.
Journal: Leukemia
Published: January 28, 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.
Journal: Frontiers in immunology
Published: November 22, 2024
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation.
Journal: EJHaem
Published: January 06, 2024
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
Journal: International journal of molecular sciences
Published: November 19, 2023
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Journal: Haematologica
Published: March 24, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026